Abstract
Background: Surgical site infections (SSI) are frequent causes of morbidity and mortality after orthopaedic oncologic procedures. This study was conducted to identify the surgical site infection rate following a lower extremity or pelvic procedure and assess the risk factors for acquiring SSI by direct observation of orthopaedic oncology patients’ wounds at a comprehensive cancer center.
Methods: One hundred ten consecutive patients were prospectively studied. The surveillance of surgical site infections was carried out by a surgeon-trained nurse from the Infectious Disease Service. Nineteen variables were analyzed as risk factors.
Results: The overall SSI rate was 13.6% (15 of 110). Excluding those patients with known preoperative infections, the SSI rate was 9.5% (10 of 105). Two statistically significant risk factors for surgical site infection in these patients emerged in the multivariate analysis: blood transfusion (P = .007) and obesity (P = .016). Procedure category was significant in univariate analysis only. Preoperative length of stay, length of procedure, prior adjuvant treatment (chemotherapy or radiotherapy), prior surgery, and use of an implant or allograft were not statistically significant risk factors for wound infection. Antibiotic usage patterns did not influence SSI rate.
Conclusions: Blood transfusion and obesity should be considered individual risk factors for the development of wound infection in patients having orthopaedic oncologic procedures.
Similar content being viewed by others
REFERENCES
Haley RW, Culver DH, White JW, et al. The nationwide nosocomial infection rate. A new need for vital statistics. Am J Epidemiol 1985; 121: 159–67.
Smyth ET, Emmerson AM. Surgical site infection surveillance. J Hosp Infect 2000; 45: 173–84.
De Boer As, Mintjes-de Groot AJ, Severijnen AJ, et al. Risk assessment for surgical-site infections in orthopedic patients. Infect Control Hosp Epidemiol 1999; 6: 402–7.
Mangram AJ, Horan TC, Pearson ML, et al. Guideline for the prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol 20; 247–80: 1999.
Wenzel RP. The economics of nosocomial infections. J Hosp Infect 1995; 31: 79–87.
Lew D, Pittet D, Waldvogel F. Infections that complicate the insertion of prosthetic devices. In: Mayhall CG, ed. Hospital Epidemiology and Infection Control. Baltimore: Williams & Wilkins, 1996; 731–48.
Kawai A, Boland P, Lin P, et al. Relationship between magnitude of resection, complication, and prosthetic survival after prosthetic knee reconstructions for distal femoral tumors. J Surg Oncol 1999; 70: 109–15.
Meyers PA, Heller J, Healey JH, et al. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol 1992; 10: 5–15.
Horan TC, Culver DH, Gaynes RP, et al. Nosocomial infections in surgical patients in the United States, January 1986–June 1992. National Nosocomial Infections Surveillance (NNIS) System. Infect Control Hosp Epidemiol 1993; 2: 73–80.
Freitas PF, Campos ML, Cipriano ZM. Suitability of the NNISS risk index to predict the incidence of surgical site infection. Rev Assoc Med Bras 2000; 46: 359–62.
Bengston S. Prosthetic osteomyelitis with special reference to the knee: risks, treatment and costs. Ann Med 1993; 25: 523–9.
Miller WE, Counts GW. Orthopedic infections: a prospective study of 378 clean procedures. South Med J 1975; 4: 386–91.
Complications of arthroscopy and arthroscopic surgery: results of a national survey. Committee on Complications of Arthroscopy Association of North America. Arthroscopy 1985; 1: 214–20.
Lew D, Waldvogel F. Infections in skeletal prosthesis. In: Bennett JV, Brachman PS, eds. Hospital Infections. 4th ed. Philadelphia: Lippincott-Raven, 1998; 613–20.
Velasco E, Thuler LC, Martines CA, et al. Risk index for prediction of surgical site infection after oncology operations. Am J Infect Control 1998; 3: 217–23.
Barber GR, Miransky J, Brown AE, et al. Direct observations of surgical wound infections at a comprehensive cancer center. Arch Surg 1995; 130: 1042–7.
Braga M, Vignali A, Radaelli G, Gianotti L, Di Carlo V. Association between perioperative blood transfusion and postoperative infection in patients having elective operations for gastrointestinal cancer. Eur J Surg 1992; 158: 531–6.
Jahnson S, Andersson M. Adverse effects of perioperative blood transfusion in patients with colorectal cancer. Eur J Surg 1992; 158: 419–25.
McAlister FA, Clark HD, Wells PS, et al. Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies. Br J Surg 1998; 85: 1162–3.
Tan MH, Mankin HJ. Blood transfusion and bone allografts. Effect on infection and outcome. Clin Orthop 1997; 340: 207–14.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Morris, C.D., Sepkowitz, K., Fonshell, C. et al. Prospective Identification of Risk Factors for Wound Infection After Lower Extremity Oncologic Surgery. Ann Surg Oncol 10, 778–782 (2003). https://doi.org/10.1245/ASO.2003.07.023
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1245/ASO.2003.07.023